EdiTy Therapeutics

Corporate Website: https://www.edity-tx.com/

EdiTy develops precision therapeutics for the genomic age, enabling targeted deployment of gene editing against diseases that are currently beyond the capabilities of modern medicine. At our core is a platform technology which aligns with the immune system of the patient, allowing for the detection and cure of diseased cells. We believe this technology will accelerate the safe and routine use of gene editing systems to improve the lives of patients who at this time suffer without prospect of a cure.